Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Obstetrics and Gynecology|October 1, 1990
Topical podofilox for the treatment of condylomata acuminata in womenD A Baker, J M Douglas, D M Buntin, et al.
Cancer|October 15, 1995
Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer RegistryM F Jishi, J H Itnyre, I A Oakley-Girvan, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Characteristics of familial ovarian cancer: a report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer RegistryM S Piver, J M Goldberg, Y Tsukada, et al.
American Journal of Clinical Oncology|December 1, 1993
Intraoperative orthovoltage radiation therapy in the treatment of recurrent gynecologic malignanciesM L Hicks, M S Piver, E Mas, et al.
Annals of Surgical Oncology|August 26, 1998
Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortalityJ M Goldberg, M S Piver, R E Hempling, et al.
Cancer Detection and Prevention|January 1, 1988
Tumor-infiltrating lymphocytes: in vitro characterization of morphological and phenotypical changesJ Halpern, A Islam, J P Simich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survivalS Kayastha, A N Freedman, M S Piver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinomaM S Piver, S B Lele, D L Marchetti, et al.
Gynecologic Oncology|November 1, 1990
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assayJ Fanning, W C Biddle, M Goldrosen, et al.
Gynecologic Oncology|August 6, 2000
Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer RegistryM S Piver, Y Tsukada, B A Werness, et al.
Pageof 29